WAUKEGAN, Ill.--(BUSINESS WIRE)--NEOPHARM, Inc. (NASDAQ: NEOL) today announced the appointment of Dr. Shahid Ali to Executive Vice President, Research & Development. Reporting to Laurence Birch, President and Chief Executive Officer of NEOPHARM, Dr. Ali will be responsible for developing a pathway forward for the Company’s drug portfolio, which will include a focus on:
